Cancer

Breast Cancer

Program Grant funding by the Medical Foundation allowed Professor Rob Baxter to explore the ways in which a protein he had previously discovered, IGFBP-3, acts as a brake on normal cell growth, and how some cancer cells have developed mechanisms to avoid this braking action, leading to uncontrolled growth.

Professor Baxter received one of the inaugural Medical Foundation Program Grants in 1995 and is the Director of the Kolling Institute of Medical Research at Royal North Shore Hospital, the University’s Department of Molecular Medicine, and head of the Growth Research Group.

Professor Baxter and his team have made many new discoveries about the processes that regulate breast cancer cell growth. These discoveries have made significant contribution to the world-wide effort to understand and control the development and progression of breast cancer.